Key result
Targeting inflammation emerges as a promising therapeutic strategy in heart failure supported by genetic evidence.
No takes yet. Share an insight, caveat, or question.
Review highlights the role of inflammation in heart failure, suggesting genetic insights can guide targeted anti-inflammatory therapies.
Mateusz Sokolski, Daniel I Bromage; Targeting Inflammation in Heart Failure - from genetic evidence to therapeutic agents., ESC Heart Failure, , xvaf030, h
Sokolski et al. (2026) studied this question. Targeting inflammation in heart failure is an evolving therapeutic approach supported by genetic evidence and emerging pharmacological agents.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: